Cargando…
Peptide Vaccine Therapy in Colorectal Cancer
Colorectal cancer is the third most common cause of cancer-related deaths and the second most prevalent (after breast cancer) in the western world. High metastatic relapse rates and severe side effects associated with the adjuvant treatment have urged oncologists and clinicians to find a novel, less...
Autores principales: | Bartnik, Aleksandra, Nirmal, Ajit Johnson, Yang, Shi-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552199/ https://www.ncbi.nlm.nih.gov/pubmed/26343847 http://dx.doi.org/10.3390/vaccines1010001 |
Ejemplares similares
-
Trial watch: Peptide vaccines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2012) -
Trial Watch: Peptide vaccines in cancer therapy
por: Aranda, Fernando, et al.
Publicado: (2013) -
Personalized peptide vaccination for advanced colorectal cancer
por: Sasada, Tetsuro, et al.
Publicado: (2015) -
Peptide-Based Vaccination Therapy for Rheumatic Diseases
por: Wang, Bin, et al.
Publicado: (2020) -
Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)